Infectious Diseases

Main Content


Study title

Stakeholder-driven comparative effectiveness study of treatments to prevent coronary artery damage in patients with resistant Kawasaki disease

  • Principal Investigator: Dr. Lisa Didion


The goal of this study is to determine the effects of an experimental drug in IVIG-resistant Kawasaki Disease (KD) patients.

Who can participate

Those eligible to participate in this study include:

  • Infants and children with acute Kawasaki Disease

For more information

  • Deepali Bhatt
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson, MS 39216
    (601) 815-9481
  • IRB Number: 2017-0173